Literature DB >> 24965079

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013).

.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24965079     DOI： 10.1253/circj.cj-66-0092

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  110 in total

1.  Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study.

Authors:  Matsuhiko Hayashi; Takayuki Abe; Mieko Iwai; Ayumi Matsui; Tadashi Yoshida; Yuji Sato; Yoshihiko Kanno
Journal:  Clin Exp Nephrol       Date:  2015-12-01       Impact factor: 2.801

2.  Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.

Authors:  Gregory Y H Lip; Flemming Skjøth; Peter Brønnum Nielsen; Jette Nordstrøm Kjældgaard; Torben Bjerregaard Larsen
Journal:  JAMA Cardiol       Date:  2017-08-01       Impact factor: 14.676

3.  Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.

Authors:  Manaka Tagaya; Daiji Yoshikawa; Yoshinori Sugishita; Fumi Yamauchi; Takehiro Ito; Tomohito Kamada; Masataka Yoshinaga; Daisuke Mukaide; Wakaya Fujiwara; Hiroatsu Yokoi; Mutsuharu Hayashi; Eiichi Watanabe; Junichi Ishii; Yukio Ozaki; Hideo Izawa
Journal:  Heart Vessels       Date:  2015-05-29       Impact factor: 2.037

4.  Effect of berberine on acetylcholine-induced atrial fibrillation in rabbit.

Authors:  Zhi-Wen Zhou; Hong-Chao Zheng; Li-Fang Zhao; Wei Li; Jian-Wen Hou; Yi Yu; Pi-Zhi Miao; Jian-Ming Zhu
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

Review 5.  New-onset atrial fibrillation: an update.

Authors:  Takeshi Omae; Eiichi Inada
Journal:  J Anesth       Date:  2018-03-09       Impact factor: 2.078

6.  Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study.

Authors:  Shigeki Kushimoto; Toshio Fukuoka; Akio Kimura; Kazunori Toyoda; Andres Brainsky; Amy Harman; Thomas Chung; Masahiro Yasaka
Journal:  Int J Hematol       Date:  2017-08-16       Impact factor: 2.490

7.  Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Authors:  C Fielder Camm; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

8.  Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.

Authors:  Homare Okamura; Mamoru Arakawa; Atsushi Miyagawa; Hideo Adachi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-05-02

9.  Safety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study.

Authors:  Akira Sezai; Shunji Osaka; Hiroko Yaoita; Munehito Arimoto; Hiroaki Hata; Motomi Shiono
Journal:  J Atr Fibrillation       Date:  2016-10-31

10.  Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study.

Authors:  Hisao Otsuki; Junichi Yamaguchi; Kazuho Kamishima; Hiroyuki Arashi; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2018-03-16       Impact factor: 2.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.